DDIIUK2026

#DDII #DDIIeventseries #DDIIUK2026 #Drug development #Drug discovery #Events

Drug Discovery Innovators and Investors (DDII) conference: Event summary

The second event in the Drug Discovery Innovators and Investors (DDII) event series took place on 4 November, 2026, bringing together representatives from across the UK life sciences sector to discuss the opportunities and challenges facing drug discovery and development. Held in London under the theme Technology, Scale, and Capital:… Read More

#News

London skyline
#DDII #DDIIeventseries #DDIIUK2026 #Drug development #Drug discovery #Events

Next week: DDW’s Drug Discovery Innovators and Investors (DDII) conference

DDW’s Drug Discovery Innovators and Investors (DDII) conference returns to London on 4 November, bringing together leaders from pharma and biotech, technology suppliers, academia, start-ups, spin-outs and the investment community. Date: Wednesday, 4 November 2026 Time: 09:00–17:00 Venue: etc.venues Monument, 8 Eastcheap, London, EC3M 1AE The one-day conference will explore… Read More

#News

#DDII #DDIIeventseries #DDIIUK2026 #Drug development #Drug discovery #Events

Full agenda announced for DDW’s London, UK Conference

DDW has announced the full agenda for its Drug Discovery Innovators & Investors (DDII) London, UK Conference – a full-day, in-person event focused on early-stage drug discovery and development. This event is unique in its focus on early-stage drug discovery and development. From groundbreaking science and technology to regulation, funding and partnership, DDII… Read More

#News

#DDIIeventseries #DDIIUK2026 #Events #Investment

Registration now open for Drug Discovery Innovators & Investors UK Conference

The Drug Discovery Innovators & Investors (DDII) UK Conference will take place at etc.venues Monument, London, on Wednesday 4 November. The conference brings together R&D leaders, lab managers, decision-makers from pharma and biotech companies, industry suppliers, researchers, start-ups, and investors to discuss key challenges in UK drug development. Read More

#News

#BioIndustry Association #DDII #DDIIUK2026

Chris Molloy, BIA, keynotes Drug Discovery Innovators & Investors, UK Conference

We’re delighted to announce Chris Molloy, Chief Executive Officer of the UK BioIndustry Association (BIA), as keynote speaker at Drug Discovery Innovators & Investors, London, UK Conference. The conference theme, Technology, Speed, Scale, and Capital: Advancing UK Drug Discovery and Development, will bring together senior executives, R&D leaders, lab managers… Read More

#Editor's Choice #News